cigna coverage glp 1 drops of GLP-1 obesity drugs for its own employees Cigna is making GLP-1 coverage
Description
FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
Compounded GLP-1 semaglutide oral drops.
However, weight loss with these drugs also could lower risk for obesity-related cancers
64% below iron RDA, 72% below calcium RDA, only 1.4% met vitamin D recommendations
Specially formulated with Resveratrolto help rebuild and rebalance the gut microbiome
